Furthermore, we are always seeking more
effective vaccines based on current research.
Not exact matches
«
Based on recent progress, I believe world leaders could help make an
effective AIDS
vaccine a reality within the next decade,» Gates says.
Based on preliminary effectiveness estimates, the CDC estimates that the flu
vaccine is approximately 25 %
effective against the H3N2 strain https://www.cdc.gov/mmwr/volumes/67/wr/mm6706a2.htm.
This new method will enable the
effective production of RNA -
based vaccines and promote the development and adoption of RNA -
based plant protection methods.
«What that suggests is that this approach really gives us broad spectrum protection, and could serve as a
basis for an
effective pre-pandemic
vaccine.»
The method is relatively new, but far bacteria -
based vaccines have proven
effective: A seasonal flu
vaccine produced by VaxInnate successfully protected humans in clinical trials, and the company's recently tested swine flu
vaccine immunized mice against the virus.
One of the
vaccines, which is
based on a recombinant vesicular stomatitis virus expressing the glycoprotein of the Zaire strain of the Ebola virus (VSV - ZEBOV), was recently shown to be extremely
effective with 100 per cent efficacy against the lethal Ebola virus disease in WHO - funded studies carried out in Guinea and Sierra Leone.
The data obtained from this study provide a
basis for more rapid, cost -
effective clinical trials to evaluate new influenza drugs or to determine the efficacy of candidate
vaccines for both seasonal and pandemic influenza.
A school -
based flu
vaccine program in the Denver Public Schools was
effective at reaching nearly one - third of the students, but billing and reimbursement issues posed significant problems for administrators of the program.
«Instead of dismissing families, we need a better understanding of the reasons for
vaccine refusal to find evidence -
based strategies for communication that are
effective at convincing hesitant parents to vaccinate.»
To be most
effective, DNA
vaccines need to be
based on the genes of the viruses present in the target population, so regular genetic diversity monitoring is essential, Dukhovlinova says.
PHILADELPHIA --(April 19, 2018)-- The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their ground - breaking phase 1 DNA -
based Zika
vaccine research — the first trial of a Zika
vaccine in humans, which proved safe and
effective.
For their pioneering discoveries in chemistry and parasitology, and personal commitments to translate these into
effective chemotherapeutic and
vaccine -
based approaches to control malaria - their collective work will impact millions of lives globally particularly in the developing countries.